A bombshell revelation from Britain’s Office of National Statistics today – a first dose of a non-mRNA vaccine was associated with an increased risk of death in young women.
“Receiving a first dose of a non-mRNA vaccine was associated with an increased risk of cardiac death in young women. Vaccination with the main non-mRNA vaccine used in the UK was stopped for young people following safety concerns in April 2021, and most of the young people who received it would have been prioritised due to clinical vulnerability or being healthcare workers. Therefore, these results cannot be generalised to the population as a whole.”
The “non-mRNA vaccine” vaccine that the ONS are referring to is the AstraZeneca vaccine. Millions of people across the globe have been vaccinated with it. It was suspended in countries across Europe when the problems with it became apparent – but not in time to save the lives of its many victims.
Our sincerest condolences to the families of the thousands of victims whose lives have been altered or ended by this product.
Update 1 – 29th March 2023 – One additional cardiac-registered death for every 16,500 females
The ONS study has also been covered by the famously pro-vaccine Julia Hartley-Brewer with statistician Jamie Jenkins.
Julia: “There is beginning to be a really big build up of evidence saying there is something to see here.”
Jamie: “The increased risk corresponds to one additional cardiac-registered death for every 16,500 females given the first dose between the ages of 12-29.”
Julia and statistician Jamie Jenkins discuss the latest ONS data on the AstraZeneca jab.
Julia: “There is beginning to be a really big build up of evidence saying there is something to see here.”
Jamie: "The increased risk corresponds to one additional cardiac-registered death… pic.twitter.com/OlqkpU0EFg
